Peritoneal Dialysis: How Hong Kong's Innovative Policy is Changing Kidney Care
"Discover how Hong Kong's PD-first policy is improving patient outcomes and reducing healthcare costs."
In Hong Kong, the financial strain of treating end-stage renal disease (ESRD) has led to an innovative healthcare approach. Unlike many Western countries, Hong Kong has championed peritoneal dialysis (PD) as the primary treatment for kidney failure for over three decades.
Why PD first? Peritoneal dialysis offers a practical and cost-effective alternative to hemodialysis (HD). The average annual cost of HD per patient is more than double that of PD, making it a fiscally responsible choice for a healthcare system managing an increasing number of ESRD cases.
With its PD-first policy, Hong Kong has achieved impressive results. In 2012, 72.9% of dialysis patients were treated with PD, the highest percentage globally. This success hinges on dedicated medical expertise, well-trained staff, and comprehensive patient education programs. Let's delve into how this policy works and its impact on patients' lives.
The Scale of Dialysis Need in the United States
In 2023, home dialysis use among people with end-stage renal disease (ESRD) reached its highest level in over a decade, with approximately 15% of new and established patients receiving peritoneal dialysis or home hemodialysis. This growth reflects ongoing shifts in how kidney failure is managed in the United States. Meanwhile, in 2024, 22,916 people on dialysis received a kidney transplant, representing a transplant rate of 4 per 100 person-years. The persistent gap between those needing dialysis and those receiving transplants underscores the importance of optimizing dialysis modalities, including home-based options like peritoneal dialysis.
Evolving Indications and Patient-Centered Prescribing
The indications for peritoneal dialysis have undergone a paradigm shift in recent years, with medical barriers previously viewed as contraindications—such as anuria, polycystic kidney disease, cardiovascular disease, and advanced age—now being re-examined. As the global prevalence of peritoneal dialysis continues to grow, practitioners are increasingly focused on prescribing strategies tailored to patient needs and preferences. Peritoneal dialysis offers significant benefits, including greater scheduling flexibility compared with in-center hemodialysis. High-quality PD delivery requires a person-centered, individualized shared decision-making approach that accounts for lifestyle, residual kidney function, volume status, and quality of life.
A Century-Old Concept with Ancient Roots
The concept of peritoneal dialysis as a mode of renal replacement therapy is nearly a century old, with early origins tracing back to ancient recognition of the peritoneum. The term 'peritoneum' derives from the Greek peritonaion, meaning 'to stretch around,' and the first recorded reference of the peritoneal cavity appears in the Ebers papyrus from 1550 BC. For the past several decades, peritoneal dialysis has provided patients with end-stage kidney disease a home-based treatment option that allows flexibility to maintain everyday activities, work, and travel. These historical milestones laid the groundwork for modern PD as an established dialysis modality.
The Pillars of Hong Kong's PD-First Policy: How Does It Work?
Hong Kong's PD-first policy operates on a simple yet effective principle: all patients requiring dialysis are first considered for PD unless medical contraindications exist. This approach ensures that the majority of patients benefit from this cost-effective treatment option.
- Comprehensive Education: All patients receive thorough education about both PD and HD. This ensures they understand their options and can make informed decisions.
- Financial Incentives: The Hong Kong Hospital Authority only reimburses HD for patients with medical contraindications for PD. Those who choose HD for personal preferences must cover the costs themselves.
- Centralized Planning: Since 1985, the Central Renal Committee has standardized renal services in Hong Kong, ensuring consistent and effective implementation of the PD-first policy.
Recent Advances in Peritoneal Dialysis
Peritoneal dialysis remains the preferred dialysis modality for most children with end-stage renal disease, and advances in treatment have led to increased technique and patient survival. In the United States, continued growth in peritoneal dialysis use over the past 15 years has been driven largely by policy and payment reforms such as the End-Stage Renal Disease Prospective Payment System and the Advancing American Kidney Health Initiative. PD offers several potential benefits over in-center hemodialysis, including greater patient autonomy and reduced healthcare resource utilization. Ongoing research continues to refine clinical practices and expand access to this home-based therapy.
Challenges and Limitations of Peritoneal Dialysis
Peritoneal dialysis is not without challenges that may limit its adoption or long-term success for certain patients. Peritonitis remains a significant complication, with hospitalization rates for this condition representing a major concern for PD patients. Some clinicians hold preconceptions about PD that may act as barriers to its broader use, particularly regarding patient selection and expected outcomes. Additionally, technique failure over time can necessitate a transition to hemodialysis, which may disrupt patients' lives and increase healthcare costs. These challenges highlight the need for ongoing improvements in patient education, infection prevention, and clinical support.
Comparing Peritoneal Dialysis and Hemodialysis
The two primary modalities for managing end-stage renal disease are hemodialysis and peritoneal dialysis, each with distinct mechanisms, benefits, and drawbacks. Only a few randomized controlled trials have directly evaluated PD versus HD, making comprehensive comparisons challenging. Peritoneal dialysis offers home-based flexibility and a more self-directed schedule, while in-center hemodialysis provides supervised treatment in a clinical setting. Factors such as dietary restrictions, training requirements, infection risk, and lifestyle preferences influence which modality may be most appropriate for individual patients. Clinical outcomes and patient quality of life can vary between the two approaches depending on patient characteristics and care delivery.
Looking Ahead: Maintaining and Improving the PD-First Policy
To maintain the sustainability of the PD-first policy, Hong Kong focuses on several key areas: addressing common PD-related issues, enhancing HD support, and promoting organ donation. By tackling challenges like frequent peritonitis, ultrafiltration failure, and inadequate dialysis, the healthcare system ensures better outcomes for all patients. Ultimately, Hong Kong's PD-first policy serves as a model for other regions facing similar healthcare challenges. Its success demonstrates that prioritizing cost-effective, patient-centered care can lead to significant improvements in public health.
Expert Perspectives on Peritoneal Dialysis Adoption
Peritoneal dialysis is recognized as a lower-cost dialysis modality with non-inferior clinical outcomes compared to hemodialysis. Recent federal initiatives have emphasized shifting dialysis from in-center to home modalities, namely PD. However, such policy has been slow to impact the distribution of HD and PD due to multiple barriers, including provider-level factors and clinician preconceptions about its use. Despite the growing number of patients requiring kidney replacement therapy, peritoneal dialysis remains underutilized globally. These expert perspectives suggest that addressing clinician myths and systemic barriers is essential to realizing PD's full potential.
Looking Ahead for Peritoneal Dialysis
Peritoneal dialysis continues to evolve as innovations in technology and clinical practice expand its applicability. Researchers are exploring ways to improve long-term technique survival and reduce complications such as peritonitis. Greater emphasis on patient-centered care and shared decision-making may help increase PD uptake globally. As healthcare systems seek cost-effective solutions for the growing burden of kidney disease, peritoneal dialysis is positioned to play an increasingly important role in renal replacement therapy.
Systemic Barriers to Widespread PD Adoption
Despite its benefits, peritoneal dialysis faces systemic challenges that hinder its broader adoption. Provider education and training gaps may limit clinicians' confidence in prescribing and managing PD patients. Healthcare infrastructure and reimbursement models in some regions may not adequately support home-based dialysis programs. Addressing these systemic barriers requires coordinated efforts among policymakers, healthcare providers, and patient advocacy groups to create environments where PD can thrive as a viable treatment option.
Patient Outcomes and Global Perspectives
Kidney failure treated with hemodialysis or peritoneal dialysis is a major global health problem associated with increased risks of death and hospitalization. Global studies have compared the incidence and causes of death and hospitalization during the first year of HD or PD among countries, revealing significant variation in outcomes. Long-term outcome analyses between PD and HD in real-world contexts remain limited but essential for informing clinical practice. Peritonitis continues to be the primary cause of treatment failure among patients on continuous ambulatory peritoneal dialysis, highlighting the critical role of dialysis nurses and clinical teams in managing complications.